Scandion Oncology A/S

OM:SCOL BTA Stock Report

Market Cap: SEK 240.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Scandion Oncology Balance Sheet Health

Financial Health criteria checks 6/6

Key information

0%

Debt to equity ratio

DKK 0

Debt

Interest coverage ration/a
CashDKK 87.97m
EquityDKK 91.67m
Total liabilitiesDKK 9.59m
Total assetsDKK 101.26m

Recent financial health updates

No updates

Recent updates

No updates

Financial Position Analysis

Short Term Liabilities: SCOL BTA's short term assets (DKK95.9M) exceed its short term liabilities (DKK8.3M).

Long Term Liabilities: SCOL BTA's short term assets (DKK95.9M) exceed its long term liabilities (DKK1.3M).


Debt to Equity History and Analysis

Debt Level: SCOL BTA is debt free.

Reducing Debt: SCOL BTA had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SCOL BTA has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: SCOL BTA has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 52.7% each year.


Discover healthy companies